Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia

Haematologica. 2017 Sep;102(9):e332-e335. doi: 10.3324/haematol.2017.166124. Epub 2017 May 18.

Authors

Ana Valencia-Martinez¹, Alessandro Sanna¹, Erico Masala¹, Elisa Contini², Alice Brogi^{1

3}, Antonella Gozzini¹, Valeria Santini⁴

Affiliations

¹ Department of Hematology, Università degli Studi di Firenze, AOU Careggi, Florence, Italy.
² SOD Diagnostica Genetica, University of Siena, Italy.
³ Department of Biotechnologies, University of Siena, Italy.
⁴ Department of Hematology, Università degli Studi di Firenze, AOU Careggi, Florence, Italy valeria.santini@unifi.it.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Disease Progression
Female
Follow-Up Studies
Humans
Leukemia, Myelomonocytic, Chronic / genetics*
Male
Middle Aged
Mutation*
Myelodysplastic Syndromes / pathology*
Repressor Proteins / genetics*
Retrospective Studies

Substances

ASXL1 protein, human
Repressor Proteins